We hope the resources available on this site will be helpful to people with relapsing forms of MS, their caregivers and the healthcare professionals who treat them. Please note that Mylan is not responsible for the content on any non-Mylan website listed in this section.
Download free tools and patient guides from Mylan.
Connect with the MS community, explore other websites designed for you and your caregivers and learn more about generic drugs.
Uncompromising Support for Patients with Relapsing Forms of MS
For Patients With Relapsing Forms Of Multiple Sclerosis
Injection Prep Mat (for Autoinjector)
Injection Prep Mat (for Pre-filled Syringe)
Injection Site Rotation Plan
Mylan ADVOCATE® and Glatiramer Acetate Injection Brochure
Guide for Self-injection with WhisperJECT® Autoinjector
GLATIRAMER ACETATE INJECTION is a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
IMPORTANT SAFETY INFORMATION
Do not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.
Some patients report a short-term reaction right after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection. Call your doctor right away if you have any of these symptoms and do not give yourself more injections until your doctor tells you to.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain usually only lasts a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain.
A permanent indentation under the skin (lipoatrophy and, rarely, death of your skin tissue also referred to as necrosis) at the injection site may occur due to local destruction of fat tissue. Be sure to follow your doctor’s instruction on how to use glatiramer acetate injection and be sure to choose a different injection site each time you use glatiramer acetate injection.
The most common side effects in studies of GLATIRAMER ACETATE INJECTION are redness, pain, swelling, itching, or a lump at the site of injection, rash, shortness of breath, and flushing. These are not all the possible side effects of GLATIRAMER ACETATE INJECTION. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects that you have while taking GLATIRAMER ACETATE INJECTION.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.